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Objective: To determine the effectiveness of a model osteoarthritis consultation, compared with usual
care, on physical function and uptake of National Institute for Health and Care Excellence (NICE) oste-
oarthritis recommendations, in adults 45 years consulting with peripheral joint pain in UK general
practice.
Method: Two-arm cluster-randomised controlled trial with baseline health survey. Eight general prac-
tices in England. Participants: 525 adults 45 years consulting for peripheral joint pain, amongst 28,443
population survey recipients. Four intervention practices delivered the model osteoarthritis consultation
to patients consulting with peripheral joint pain; four control practices continued usual care.
The primary clinical outcome of the trial was the SF-12 physical component score (PCS) at 6 months; the
main secondary outcome was uptake of NICE core recommendations by 6 months, measured by oste-
oarthritis quality indicators. A Linear Mixed Model was used to analyse clinical outcome data (SF-12 PCS).
Differences in quality indicator outcomes were assessed using logistic regression.
Results: 525 eligible participants were enrolled (mean age 67.3 years, SD 10.5; 59.6% female): 288 from
intervention and 237 from control practices. There were no statistically signiﬁcant differences in SF-12
PCS: mean difference at the 6-month primary endpoint was 0.37 (95% CI 2.32, 1.57). Uptake of core
NICE recommendations by 6 months was statistically signiﬁcantly higher in the intervention arm
compared with control: e.g., increased written exercise information, 20.5% (7.9, 28.3).
Conclusion: Whilst uptake of core NICE recommendations was increased, there was no evidence of
beneﬁt of this intervention, as delivered in this pragmatic randomised trial, on the primary outcome of
physical functioning at 6 months.
Trial registration: ISRCTN06984617.
© 2017 The Authors. Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.
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Osteoarthritis (OA) is a major cause of pain and disability in
older adults: musculoskeletal pain in adults aged 45 years and
over is the number one cause of years lived with disability
worldwide1. Routine OA management in UK general practice has
been found to lack adherence to guidelines produced by the Na-
tional Institute for Health and Care Excellence (NICE)2, updated in
20143, especially for ‘core’ self-management approaches such as
written information, exercise and weight loss4e6. Implementation
of the NICE recommendations has not yet been evaluated in UK
general practice.
Healthcare professionals often frame consultations in terms
(such as ‘wear and tear’) thought to reassure patients or be patient-
friendly which may have a negative impact7. Patients and general
practitioners (GPs) want more advice and support on understand-
ing OA and the use of non-pharmacological approaches6,7. Patient
perceived health service needs have also been found to align with
clinical guideline recommendations8.
The MOSAICS (Managing OSteoArthritis In ConsultationS) study
was a cluster-randomised controlled trial to investigate the effec-
tiveness of a complex intervention e a model OA consultation
(MOAC) e on clinical outcomes, and on the uptake of core NICE OA
core recommendations in participants aged 45 years consulting
their GP with peripheral joint pain (hand, hip, knee, foot).
Methods
Design
The MOSAICS study had two key parts: (1) a population health
survey that took place between May 2011 and April 2012, prior to
(2) a two-arm cluster-randomised controlled trial conducted in
eight general practices in Cheshire, Shropshire or Staffordshire,
UK. The protocol has been published9 and we have previously
reported the practice-level evaluation of the intervention using
anonymised medical records10. By using medical record informa-
tion for measuring the outcomes, all eligible patients in the
practices were included but no patient reported outcomes were
analysed by Jordan et al.10. Here we report the patient-level
evaluation of the clinical effectiveness of the MOAC intervention
in patients with OA and describe the uptake of core NICE OA
recommendations for those patients who gave consent to be part
of the clinical outcomes study.
Given the practice-level unit of randomisation, it was impor-
tant to avoid the potential for bias in selection and recruitment of
participants. We used a population health survey to pre-
determine potentially eligible participants prior to consultation
for joint pain to establish baseline characteristics as the majority
of the population are registered with a GP in England. This was
mailed to all patients aged 45 years eligible to receive a postal
survey and registered with one of the eight general practices
participating in the MOSAICS study. Survey participants were
asked questions about any joint pain and general health, as well as
for permission for further contact and medical record review.
Those who subsequently consulted their GP for joint pain during
the trial recruitment phase were invited to take part in the cluster
trial. Eligibility of potential participants for the cluster trial was
identiﬁed at this stage and GPs and practice nurses therefore
played no role in determining eligibility for recruitment to the
cluster trial.
The cluster trial was conducted from May 2012 through to
February 2014 by the Arthritis Research UK Primary Care Centre,
Keele University, UK.Setting and participants
General practices
Ten general practices, all using the EMIS electronic health re-
cords (EHR) system, were invited to participate. Eight practices
consented to take part. Eligibility of practices has been described
elsewhere9. Reasons for non-participation included recent
engagement with teaching medical students and other research
involvement. The combined population of patients aged 45 years
registered with the eight participating general practices (estimate
30,000) formed the study sampling frame. Resources to support
general practice engagement were offered via the UK National
Institute of Health Research Clinical Research Network9.
During a 6month run-in period, all practices received a resource
pack of written advice with examples of patient leaﬂets about OA
provided by Arthritis Research UK and Arthritis Care. An OA
consultation e-template was designed to collect information on
quality indicators of OA care11. The e-template was installed in all
eight practices for the 6 month baseline period prior to random-
isation, to make the recording of joint pain consultations part of
routine care and determine any effect of the e-template on practice.
The e-template was triggered in consultations through entry of any
Read system morbidity code for clinical OA (peripheral joint pain e
hand, hip, knee, foot); these same Read codes were used to identify
patients for the trial. The effects of the e-template have previously
been reported11. Brieﬂy, the e-template was associated with
increased recording of weight measurement and increased pre-
scription of NICE-recommended analgesics (topical NSAIDs, para-
cetamol) in the run-in period, but other care remained stable.
Following the 6-month run in period, practices were rando-
mised into intervention (four practices) or usual care (four prac-
tices). All eight practices continued to use the e-template
introduced at baseline9,11 to routinely record care in all consulta-
tions for joint pain during the study period regardless of subse-
quent recruitment to the trial.
Eligibility criteria for the health survey and the trial are
described in Dziedzic et al.9 and Appendix 1.
Participants
Eligible registered adults (Dziedzic et al.9, and Appendix 1) from
the eight practices aged 45 years were mailed a health survey
between May 2011 and February 2012. Potential trial participants
were survey responders reporting peripheral joint pain who pro-
videdwritten consent to further contact andmedical record review.
Those who subsequently consulted their GP for peripheral joint
pain during the 9 month recruitment phase (from April to
December 2012) were invited to take part in the cluster trial.
Fortnightly searches in the medical records identiﬁed when the OA
template had been opened on tagged records which allowed for
identiﬁcation of eligible participants.
Invitations were mailed 2 weeks after the GP consultation,
together with a study information sheet and a questionnaire (the
‘post-consultation baseline’) on joint pain, self-management ap-
proaches, health status and resource use9.
Randomisation
Following the six-month run-in period, general practices were
randomly allocated by administrative staff at the Keele Clinical
Trials Unit (who had no clinical involvement in the trial) to two
arms using a computer random number generator with block
randomisation stratiﬁed by practice list size (block size, 4): to
intervention (MOAC) plus e-template (n ¼ 4) or control (usual care)
plus e-template (n ¼ 4). The Principal Investigator and trial
administrative members who entered the data were unaware of
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until after the intention-to-treat analysis (blinding was broken for
per-protocol analysis).
Intervention
Practices delivered the MOAC described in full in Appendix 2,
which consisted of: an enhanced GP consultation to make, give
and explain the diagnosis, and provide initial care for older adults
presenting with peripheral joint pain; an OA Guidebook offered
by the GP to patients to support OA self-management (https://
www.keele.ac.uk/media/keeleuniversity/ri/primarycare/pdfs/OA_
Guidebook.pdf); advice on analgesia; and up to four follow-up
practice nurse consultations to guide patients in self-
management for OA with advice on weight management if
required, general exercise, and physical activity, with goal-setting
as appropriate. The development of the intervention has been
published elsewhere9,12,13. Brieﬂy, the intervention followed the
Whole Systems Informing Self-Management Engagement (WISE)
model for guided self-management14 including provision of pa-
tient information (the OA guidebook)13, care responsive to patient
needs15, and good access to follow-up care (practice nurse con-
sultations). Appendix 2 also provides full details of the training for
GPs and practice nurses.
Control
Control practices received no training, guidebook or dedicated
nurse OA clinic and continued usual care as in the pre-
randomisation period.
Patient-level evaluation
The primary outcome for clinical effectiveness was the SF-12
physical component score (PCS) at 6 months16. Uptake of NICE
core recommendations during the 6 months following the index
consultation was measured by self-reported quality indicators of
OA care17. Self-management and patient enablement were also
measured by questionnaires9,18.
Secondary outcomes included measures of pain (peripheral
joint pain intensity, OMERACT/OARSI responder criteria19), joint
problem self-management (Arthritis Self- Efﬁcacy pain subscale),
physical activity (IPAQ, Physical Activity Scale for the Elderly
[PASE]), and Global Assessment of Change9. For further details of
OMERACT/OARSI responder criteria see footnote to Supplementary
ﬁle, Table III. Measures of mental health included the SF-12 mental
component summary (MCS), the eight-item Patient Health Ques-
tionnaire depression scale (PHQ8) and seven-item Generalised
Anxiety Disorder Questionnaire (GAD7)9.
Questionnaires were administered by mail after the index
consultation (‘post-consultation baseline’) and at three, six and 12
months to determine short, medium and longer term outcomes.
Non-responders were invited to complete a minimum data
collection. The EQ-5D outcome measure was collected to inform
the cost-effectiveness analysis, to be reported separately.
Treatment ﬁdelity
To investigate the extent to which participants received the
practice nurse component of the MOAC intervention, the content,
number and percentage of participants in the intervention arm
having had a practice nurse consultation for OA were identiﬁed
from case report forms and medical records.
Sample size
With no prior data on quality indicators of OA in UK primary
care, we used the primary clinical outcome (SF-12 PCS) for thesample size calculation. In total, 500 participants were needed at
baseline, allowing for a 20% drop-out, to detect the effect size of
0.3 (‘small to moderate’) with 90% power and 5% two-tailed sig-
niﬁcance at the primary time-point of 6 months9. The sample size
calculation was adjusted to correct for: clustering (adjusted
intracluster correlation coefﬁcient (ICC) of 0.005); varying
practice size recruitment (including coefﬁcient of variation of 0.5);
and repeated-measures design and dropout (0.67 and 1.25
respectively)9.
Analysis
Baseline trial characteristics were compared between treatment
arms and presented at the level of: (1) trial arms, and (2) partici-
pant characteristics. Longitudinal linearmixedmodels were used to
analyse health outcomes: a 3-level hierarchical analysis was carried
out accounting for clustering at the levels of GP-Practice and indi-
vidual participants through repeated measures across time
0 (baseline), 3, 6 and 12 months e including time  group in-
teractions to estimate the treatment effect across the three follow
up timepoints. Fixed-covariate adjustments were made for age,
gender, baseline SF-12 PCS, corresponding patient baseline score
and practice size (speciﬁed a priori within the analysis plan). All
baseline responders were included in the dataset and the analyses
accounted for missing data under the ‘missing at random’ (MAR)
assumption by modelling the interaction of baseline covariates and
time e hence retaining the intention-to-treat principle. For
dichotomous ‘quality-indicators’ outcomes, multiple imputation
was used to account for missing data (assuming MAR) with odds
ratio estimates derived from 2-level hierarchical logistic regression
models adjusted for age, gender and practice size (with GP-Practice
as random factor): Absolute percent difference estimates were
calculated through applying derived odds ratios (intervention vs
control (reference)) to observed prevalence ﬁgures in the control
arm. Statistical signiﬁcance is at the 5% (two tailed) level. Analysis
was carried using SPSS v.21 (IBM Corp, 2012) and STATA v.13.0/14.0
(Stata Corp, 2013/5). Sensitivity analyses were conducted for the
primary clinical outcome (SF-12 PCS) (Detailed in Supplementary
ﬁle, Table I).
Results
Study recruitment and follow-up
Mean (SD) practice size for the four intervention practices was
10,240.5 (9174.8) and mean number of GPs was 6.0 (6.1), compared
with 6983.3 (2060.7) and 5.2 (2.9) respectively for the four control
practices. Trial eligibility, recruitment and follow-up are shown in
Fig. 1. Of 15,083 eligible responders reporting joint pain and con-
senting to medical record review in the health survey, 651 partic-
ipants subsequently consulted for peripheral joint pain during the
6 month recruitment period and were invited to take part in the
cluster trial. 525 consented with 288 patients recruited from
intervention practices and 237 from control practices.
The median (inter-quartile range) time between the index
consultation and response to the post-consultation baseline ques-
tionnaire was 28 (21,40) days for the intervention group, 29 (22,40)
for the control group. The mean age (SD) was 67.3 years (10.5);
59.6%, were female; 81% had multisite pain (pain in two or more of
hand, hip, knee, foot). Overall, differences in participant charac-
teristics across treatment arms at post-consultation baseline were
small (Table I). Overall follow-up rates (including minimum data
collection) were: 3 months, n ¼ 470 (89.5%), 6 months, n ¼ 424
(80.8%), 12 months, n ¼ 384 (73.1%). Rates of loss to follow-up were
similar for both trial arms (Fig. 1).
Fig. 1. Study ﬂow chart.
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Table I
Summary of General Practice (GP) and individual participant characteristics at baseline by study group
GP Practice characteristics* Intervention n ¼ 4 Control n ¼ 4
Practice size, mean (SD) 10,240 (9174.8) 6983 (2060.7)
Practice Index of Multiple Deprivation rank, median (IQR) 9165.0 (2195.7, 19,478.5) 14,633.5 (4571.5, 28,822.0)
Number of General Practitioners, mean (SD) 6.0 (6.1) 5.5 (2.9)
Age (years) of GP, mean (SD) 42.2 (23.7) 42.8 (23.5)
Participants characteristics Intervention n ¼ 288 Control n ¼ 237
Gender, n (%)
Female 167 (58.0) 146 (61.6)
Male 121 (42.0) 91 (38.4)
Age (years) mean (SD) 66.9 (10.6) 67.7 (10.3)
BMI (kg m2), mean (SD) 28.1 (5.1) 28.5 (4.8)
Marital status, n (%)
Married 186 (65.0) 168 (71.0)
Separated 2 (0.7) 4 (1.7)
Divorced 29 (10.1) 13 (15.6)
Widowed 44 (15.4) 37 (15.6)
Cohabiting 10 (3.5) 9 (3.8)
Single 15 (5.2) 6 (2.5)
Employment status, n (%)
Employed 77 (27.2) 59 (25.2)
Not working/retired 206 (72.8) 175 (74.8)
Deprivation index
Median (IQR) 21,868 (15,144, 28,649) 20,182 (15,989, 24,635)
No. of pain sites, n (%)
1 55 (19.1) 45 (19.0)
2 or more 233 (80.9) 192 (81.0)
* Age and gender structure of the registered population at the practices was similar to that of North Staffordshire and of England and Wales. Practices had a range of
numbers of patients, a range of areas e semi rural to urban (small town/larger city), and a range of deprivation.
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At 6 months difference between intervention and control arms
for the primary clinical outcome (Table II) was not statistically
signiﬁcant (P  0.05) after adjustment for predeﬁned potential
confounders. Mean difference in the SF-12 PCS at 6 months (pri-
mary analysis) was 0.37 (95% CI: 2.32, 1.57) for intervention
compared to the control group, which was neither clinically nor
statistically signiﬁcant; equating to a standardised mean difference
(effect size relative to baseline SD of 11.26) of:0.03 (95% CI:0.21,
0.14). The crude (unadjusted) intracluster correlation (ICC) was
small: 0.006 (less than 0.001 when adjusting for baseline).Uptake of self-management and NICE recommendations
Differences between intervention and control arms for the self-
reported management offered during the 6 months after the index
consultation were statistically signiﬁcantly greater in the inter-
vention arm compared with control for core NICE OA recommen-
dations: information/advice about exercises (% difference [95% CI])
20.5% (7.9%, 28.3%); and paracetamol for pain 10.7 (0.6%, 20.7%)
(Table III).Table II
Effectiveness of the model osteoarthritis consultation on the primary outcome measure
SF-12 PCS Intervention Control
Valid n Mean SD Valid n Mean
Post-consultation 280 36.49 11.48 231 36.48
3 months 250 38.03 12.32 204 38.12
6 months 229 38.99 12.12 180 38.89
12 months 200 38.79 12.58 166 39.22
ICC: 0.006 (unadjusted); <0.001 (adjusted for baseline score).
* Calculated as mean difference for Intervention group e control group by linear mixed
by general practice accounted for in the mixed model).
y Mean difference relative to pooled ‘baseline’ (post-consultation) SD.There was a reduction in self-reported use of oral NSAIDs in the
intervention arm 15.6% (28.3%, 3.5%), and less reliance on
walking aids 13.9% (24.6%, 1.6%), compared with the control
arm.
The statistically non-signiﬁcant ﬁndings for the primary clinical
outcome measure (SF-12 PCS) were largely replicated in the three
sensitivity analyses (see Supplementary ﬁle, Table I).Secondary outcomes
Differences between intervention and control were not sta-
tistically signiﬁcant for most secondary outcomes (see Table IV).
Evaluation of clinical markers of recovery (including responder
criteria) showed no signiﬁcant differences between groups (see
Supplementary ﬁle, Table III). Of the signiﬁcant differences in
secondary outcomes, the Patient Enablement Score (mean (SD))
was greater in the intervention arm compared with the control
arm at 6 months (3.21 (3.44) vs 2.29 (2.96)), and also at the
secondary endpoints of three and 12 months. By contrast PASE
scores indicated a fall in reporting of physical activity in the
intervention arm compared with control (statistically signiﬁcant
for the walking domain at three and 6 months (data not shown))(SF-12 PCS) compared to usual primary care for osteoarthritis
*Mean difference (95% CI) yEffect size (95% CI) P-value
SD
11.00 e e e
11.58 0.29 (1.86, 1.29) 0.03 (0.17, 0.11) 0.722
12.00 0.37 (2.32, 1.57) 0.03 (0.21, 0.14) 0.706
11.84 0.90 (3.75, 1.96) 0.08 (0.33, 0.17) 0.539
modelling adjusted for age, gender, practice size and baseline SF-12 PCS (clustering
Table III
Self-report quality indicators of osteoarthritis care and treatment used within the ﬁrst 6 months of consultation
Self-reported OA quality indicators Intervention Control OR (95% CI) Absolute % differenceD (95% CI) P-value
Treatment offered
zEducation, advice and access to information 95.0% 91.5% 2.95 (0.68, 12.8) 5.4% (3.5%, 7.7%) 0.148
Support on how to help self with joint problem 66.9% 60.1% 1.91 (0.95, 3.81) 14.1% (1.1%, 25.1%) 0.068
Information/advice about exercises, muscle
strengthening or physical activities
81.5% 63.3% 3.01 (1.43, 6.32) 20.5% (7.9%, 28.3%) 0.004
Referral to strengthening or physical activities 54.4% 46.9% 1.45 (0.85, 2.55) 9.2% (3.9%, 22.3%) 0.126
#Advice to lose weight 46.3% 43.0% 1.33 (0.79, 2.24) 7.0% (5.7%, 19.8%) 0.288
#Referral to services for losing weight 16.4% 12.9% 2.92 (0.85, 9.98) 17.3% (1.7%, 46.7%) 0.087
Paracetamol recommended for pain 79.7% 70.3% 1.80 (1.03, 4.25) 10.7% (0.6%, 20.7%) 0.037
Stronger painkiller 69.4% 68.8% 1.18 (0.71, 1.95) 3.4% (7.8%, 12.3%) 0.529
Information about drugs effect provided 68.2% 72.6% 0.65 (0.39, 1.09) 9.2% (21.6%, 1.6%) 0.101
Corticosteroid joint injection 35.2% 35.8% 1.12 (0.64, 1.84) 2.6% (9.6%, 14.8%) 0.677
Surgery evaluation 32.3% 37.0% 0.82 (0.42, 1.62) 4.4% (17.3%, 11.8%) 0.574
Need for walking aid assessed 28.9% 28.9% 1.05 (0.60, 1.65) 1.0% (9.3%, 11.3%) 0.853
Need for appliances/aids to daily living 14.4% 18.2% 0.91 (0.45, 1.82) 1.4% (9.1%, 10.6%) 0.780
Treatment used
zEducation, advice and access to information 62.0% 47.6% 2.67 (1.62, 4.40) 23.2% (11.9%, 32.4%) <0.001
Muscle strengthening exercises 60.5% 44.3% 1.91 (1.20, 3.20) 16.0% (4.4%, 27.5%) 0.007
General ﬁtness exercises 38.0% 35.4% 0.80 (0.45, 1.29) 4.8% (15.6%, 6.0%) 0.384
Physiotherapy 40.1% 38.6% 0.65 (0.38, 1.13) 9.5% (19.4%, 2.9%) 0.126
#Dieting to lose weight 48.4% 50.9% 0.87 (0.52, 1.44) 3.6% (16.0%, 8.9%) 0.577
Paracetamol 86.5% 84.8% 1.24 (0.63, 2.44) 2.6% (7.0%, 8.4%) 0.535
Anti-inﬂammatory creams/gels e.g., topical NSAIDs 81.6% 79.8% 1.21 (0.67, 2.21) 2.9% (7.3%, 9.9%) 0.527
Capsaicin cream 21.8% 19.4% 1.55 (0.87, 2.77) 7.7% (2.2%, 20.6%) 0.141
Anti-inﬂammatory tablets, e.g., oral NSAIDs 59.9% 70.6% 0.51 (0.31, 0.85) 15.6% (28.3%, 3.5%) 0.010
Stronger painkillers, e.g., Opioids 62.9% 62.6% 1.12 (0.70, 1.80) 2.7% (8.6%, 12.5%) 0.626
Community pharmacy 25.8% 16.5% 1.84 (1.02, 3.34) 10.2% (0.3%, 23.3%) 0.043
Walking aids 41.9% 50.4% 0.57 (0.34, 0.94) 13.9% (24.6%, 1.6%) 0.027
Shock-absorbing shoes or insoles 34.8% 31.8% 1.34 (0.81, 2.21) 6.6% (4.5%, 18.9%) 0.259
Appliances and support and braces 33.0% 36.9% 0.78 (0.44, 1.25) 5.5% (16.3%, 5.4%) 0.321
Assistive devices 25.1% 25.2% 1.35 (0.81, 2.07) 6.1% (3.7%, 15.9%) 0.222
Transcutaneous electric nerve stimulation (TENS) 16.2% 16.4% 0.98 (0.52, 1.82) 0.3% (7.1%, 9.9%) 0.944
Warmth, heat or cold application 61.2% 58.4% 1.10 (0.69, 1.75) 2.3% (9.1%, 12.7%) 0.688
Results were derived through multiple imputation of missing data using chained equations with mixed models for estimating coefﬁcients (hence, denominator population
n ¼ 525; except for # which included 390 participants classiﬁed as clinically overweight or obese (classiﬁed as having a BMI  25 kg m2)).
D Absolute percent differences were calculated by applying odds ratios derived by logistic mixed regression adjusted for age, sex and practice size to percent ﬁgures for the
reference (control group) (clustering by GP practice accounted for in the mixed model). % difference relates to % in intervention group e % in control group.
z Comprises written or verbal information about joint problem, information about treatments and advice on self-management of joint problem.
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receiving both the GP and practice nurse consultations, there was
an increase in the use of strengthening exercises at 3 months
(data not shown).
Treatment ﬁdelity
At 3 months, self-reported consultations with a practice nurse
for joint problems had occurred in n ¼ 70 (28.9%) in the interven-
tion arm compared with n ¼ 26 (13.5%) in the control arm.
Adverse events
No adverse events were reported as a result of the interventions.
Discussion
In this cluster-randomised controlled trial there was no evi-
dence of beneﬁt of this intervention, as delivered in this pragmatic
randomised trial, on the primary clinical outcome (physical func-
tioning) at 6 months after adjustment for predeﬁned potential
confounders. However, there were signiﬁcant increases in uptake
and use of NICE OA core recommendations in intervention practices
compared with control over 6 months. Use of oral NSAIDs was
reduced in participants in the intervention arm.
We developed three primary care innovations in preparation for
this trial: the MOAC, training to deliver the consultation, and an e-
template speciﬁcally for use during consultations with patients
who have OA. The model consultation consisted of an OAguidebook13,20; an enhanced OA consultation with a GP15; and
subsequent follow up with a practice nurse in a dedicated OA clinic.
The training for healthcare professionals was developed to imple-
ment delivery of the enhanced OA consultation15; and the e-tem-
plate was developed to record quality measures of OA care9,21.
These three innovations provided the tools for implementing NICE
Quality Standards for OA in general practice22.
Clinical guidelines represent a distillation of best evidence about
either clinically effective interventions and management deter-
mined by expert consensus to represent best practice, such as in-
formation provision. The challenge for clinicians and policy makers
is to get such guidelines adopted in practice. Our novel intervention
has achieved substantial improvements in adoption of the guide-
lines in primary care, and in achieving markers of quality of care for
patients with OA. Although there was a substantial increase in
guideline uptake, there remains a need to achieve universally good
adoption of recommended management options9.
Despite implementation successes in this trial, the expected
improvement in clinical outcomes did not occur. There are a
number of possible explanations. First, it is possible that the lack of
effect on clinical outcomes reﬂects a genuine lack of intervention
efﬁcacy. Considering the WISE theoretical framework as applied to
MOSAICS23, this could relate to the Guidebook, to the responsive-
ness of professionals, or to access to care (the nurse follow-up
consultations). As the cost of providing nurse clinics was reim-
bursed, and in some cases staff were directly provided, it seems
unlikely that insufﬁcient clinic availability was the cause of low
uptake but other service pressures or patient or clinician beliefs
about OA may have affected access to the practice nurse7. The GP
Table IV
Effectiveness of the model osteoarthritis consultation compared to usual primary care for osteoarthritis: evaluation of secondary outcomes
Outcome Intervention Control *Mean difference (95% CI) yEffect size (95% CI) P-value
Valid n Mean SD Valid n Mean SD
Pain intensity scores
Hip
Post-consultation 274 3.52 3.47 234 3.38 3.34 e e e
3 months 241 2.98 3.16 190 3.04 3.28 0.19 (0.63, 0.26) 0.06 (0.18, 0.08) 0.415
6 months 212 2.59 3.09 172 2.78 3.17 0.24 (0.78, 0.30) 0.07 (0.23, 0.09) 0.382
12 months 187 2.79 3.13 155 2.71 2.97 0.15 (0.90, 0.59) 0.04 (0.26, 0.17) 0.687
Knee
Post-consultation 278 5.67 3.09 230 5.63 3.28 e e e
3 months 247 4.64 3.11 195 4.69 3.14 0.49 (0.94, 0.05) 0.15 (0.30, 0.02) 0.031
6 months 215 4.27 3.01 173 4.68 3.17 0.20 (0.74, 0.34) 0.06 (0.23, 0.11) 0.468
12 months 190 4.25 3.32 159 3.89 3.08 0.04 (0.71, 0.80) 0.01 (0.22, 0.25) 0.909
Hand
Post-consultation 273 2.94 3.11 230 2.99 3.22 e e e
3 months 245 2.62 2.83 194 2.61 2.86 0.15 (0.56, 0.25) 0.05 (0.18, 0.08) 0.458
6 months 213 2.57 2.78 170 2.89 3.02 0.09 (0.57, 0.38) 0.03 (0.18, 0.12) 0.697
12 months 189 2.80 2.86 157 2.91 3.02 0.40 (1.04, 0.24) 0.13 (0.33, 0.08) 0.218
Foot
Post-consultation 275 2.79 3.12 231 2.97 3.34 e e e
3 months 245 2.36 2.85 192 2.44 3.04 0.03 (0.41, 0.47) 0.01 (0.13, 0.15) 0.904
6 months 209 2.43 2.92 170 2.46 3.08 0.30 (0.23, 0.83) 0.09 (0.07, 0.26) 0.272
12 months 189 2.48 3.05 157 2.45 3.14 0.27 (0.45, 0.99) 0.08 (0.14, 0.31) 0.461
WOMAC physical function
Post-consultation 283 12.28 7.61 233 12.09 6.87 e e e
3 months 250 10.56 7.73 196 10.32 6.84 0.36 (1.24, 0.52) 0.05 (0.17, 0.07) 0.417
6 months 219 9.67 7.21 175 10.46 7.10 0.53 (1.68, 0.61) 0.07 (0.23, 0.08) 0.362
12 months 191 10.24 7.53 161 9.28 6.65 0.13 (1.64, 1.90) 0.02 (0.23, 0.26) 0.884
AIMS 2 hand & ﬁnger function
Post-consultation 279 1.62 2.04 233 1.82 2.53 e e e
3 months 243 1.64 2.09 197 1.56 2.05 0.16 (0.16, 0.48) 0.07 (0.07, 0.21) 0.331
6 months 220 1.55 2.10 175 1.73 2.26 0.02 (0.35, 0.39) 0.01 (0.15, 0.17) 0.932
12 months 192 1.51 2.11 161 1.70 2.21 0.17 (0.67, 0.33) 0.07 (0.29, 0.14) 0.505
IPAQ
Post-consultation 200 2745 3285 171 3125 3830 e e e
3 months 182 2378 2912 157 3306 4073 693 (1447, 60) 0.20 (0.41, 0.02) 0.071
6 months 181 2200 2967 144 2519 2787 629 (1397, 139) 0.18 (0.41,0.02) 0.108
12 months 167 2356 2414 142 3041 3460 595 (1396, 207) 0.17 (0.39,0.06) 0.146
Physical activity for the elderly (PASE)
Post-consultation 237 138.7 75.9 195 147.5 85.3 e e e
3 months 203 123.6 72.0 176 149.1 90.6 22.1 (35.7, 8.5) 0.28 (0.44, 0.11) 0.001
6 months 190 123.0 68.7 143 136.2 73.2 18.3 (34.0, 2.6) 0.23 (0.42, 0.03) 0.022
12 months 157 134.2 69.6 142 148.2 77.9 17.0 (38.2, 4.1) 0.21 (0.48, 0.05) 0.127
PHQ8
Post-consultation 286 5.02 5.24 235 4.45 4.65 e e e
3 months 248 4.36 4.50 199 3.85 4.64 0.38 (0.29, 1.04) 0.08 (0.06, 0.21) 0.265
6 months 223 4.07 4.87 174 4.29 4.74 0.02 (0.74, 0.78) 0.00 (0.15, 0.16) 0.965
12 months 194 4.06 4.74 162 3.96 4.81 0.16 (1.18, 0.86) 0.03 (0.24, 0.17) 0.759
GAD7
Post-consultation 273 3.70 4.89 231 3.22 4.33 e e e
3 months 242 3.16 4.32 195 2.90 4.60 0.07 (0.72, 0.58) 0.02 (0.15, 0.12) 0.825
6 months 212 2.72 4.05 172 2.73 4.28 0.60 (0.15, 1.35) 0.13 (0.03, 0.29) 0.115
12 months 187 2.90 4.31 159 2.75 3.84 0.45 (1.47, 0.57) 0.10 (0.32, 0.12) 0.388
SF-12 MCS
Post-consultation 280 50.24 11.34 231 51.14 10.91 e e e
3 months 250 51.04 10.74 204 50.91 11.13 0.09 (1.64, 1.82) 0.01 (0.15, 0.16) 0.917
6 months 229 50.90 10.81 180 50.79 10.66 0.18 (2.11, 1.75) 0.02 (0.19, 0.16) 0.853
12 months 200 51.49 10.74 166 51.34 10.11 0.08 (2.39, 2.55) 0.01 (0.22, 0.23) 0.947
Arthritis self-efﬁcacy pain subscale
Post-consultation 282 5.40 1.99 232 5.39 2.11 e e e
3 months 246 5.82 2.18 190 5.82 2.13 0.13 (0.50, 0.25) 0.06 (0.25, 0.12) 0.516
6 months 218 5.86 2.08 173 5.82 2.31 0.00 (0.44, 0.43) 0.00 (0.22, 0.21) 0.984
12 months 197 5.83 2.24 157 6.04 2.17 0.15 (0.74, 0.44) 0.07 (0.36, 0.22) 0.615
Patient enablement
Post-consultation e e e e e e e e e
3 months 253 2.82 3.16 202 2.61 3.25 0.86 (0.10, 1.63) 0.27 (0.03, 0.51) 0.027
6 months 224 3.21 3.44 178 2.29 2.96 1.34 (0.59, 2.10) 0.42 (0.18, 0.65) <0.001
12 months 198 2.80 3.18 162 2.59 3.19 0.88 (0.05, 1.71) 0.27 (0.02, 0.53) 0.039
ICC (unadjusted): Hip pain <0.001; Knee pain <0.001; Hand pain 0.003; Foot pain 0.016; WOMAC-pf <0.001; AIMS <0.001; IPAQ <0.001; PASE <0.001; PHQ <0.001; GAD
<0.001; SF-MCS 0.001; self-efﬁcacy 0.001; patient enablement 0.010.
* Calculated as mean difference for Intervention e Control score by linear mixed modelling adjusted for age, gender, practice size and corresponding baseline measures
(clustering by GP Practice accounted for in the mixed model).
y Mean difference relative to pooled ‘baseline’ (post-consultation) SD except for patient enablement for which the relative SD was that of the SD at follow up (since no
baseline patient enablement was collected).
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reason why more patients didn't see the nurse.
Most participants had multisite, chronic, joint pain so perhaps it
was unrealistic to expect changes in a primary outcome with an
endpoint of 6 months for a long-term condition, particularly if
patients were not already engaged in positive lifestyle behaviours.
More specialist clinical services and referral for specialist pain-
management may have been indicated for some.
Secondly, the clinical outcome measures used may be inappro-
priate in routine practice for patients with multisite OA and mul-
tiple morbidities, who may be different to participants in OA
clinical trials; in particular in the guidelines the evidence base may
have been drawn from a narrower clinical spectrum of OA. Thirdly,
the ‘dose’ of the intervention in practice may have been insufﬁcient
to improve long-term pain and disability e for example less than a
third of participants reported consulting the nurse, the focus of the
intervention was on supporting self-management, and uptake of
exercise (known to be clinically effective for OA24) may not have
been of sufﬁcient intensity to achieve additional changes in the SF-
12 PCS. Finally, closing the gap between uptake of guideline evi-
dence and primary care practice may beneﬁt from multiple stra-
tegies, and the best way of combining strategies is unknown25.
Further work is still needed to explore how optimal OA manage-
ment can be provided in primary care.
Of the secondary outcomes, improvement in patient enable-
ment suggests a beneﬁcial effect of the intervention on the capacity
of patients for self-management e one of the targets of NICE core
guidance.
Strengths and limitations
Bias in cluster trials due to differential selection of patients
between intervention and control arms is a recognised problem26.
We designed our cluster trial to address these challenges by
including a pre-recruitment population survey mailed to 30,000
community dwelling adults aged 45 years registered in primary
care in order to identify potentially eligible participants prior to any
consultation about OA. When any of the individuals subsequently
consulted their GP with peripheral joint pain, and the GP entered a
relevant Read code into the patient's electronic patient record, the
patient automatically became eligible for the trial and was posted a
baseline post-consultation questionnaire to complete.
By removing the process of eligibility checking and recruitment
from the GP, we reduced the likelihood of selection bias between
intervention and control practices. However, in the intervention
practices in this pragmatic trial, it was clear that GPs had been se-
lective to some extent in their referral of patients for practice nurse
consultation, although numbers were too small to ascertain on
which characteristics patients were selected. Other design strengths
included randomisation procedures, blinding of the research nurse
and use of minimal data in follow-up. Another strength of the
MOSAICS study was its use of implementation theories9,15,27e30.
Patient and Public Involvement and Engagement was used
extensively throughout the MOSAICS study, including in co-
application for funding, steering group membership, OA guide-
book development and selection of measures of self-reported
quality of OA primary care9,17,31.
A weakness of our study was that not all participants recruited
in the intervention arm received the linked practice nurse consul-
tation, which could have diluted the impact of the intervention.
Less than a third of participants in the intervention arm saw the
practice nurse; further analysis did not reveal a clear underlying
reason for this.
Since the NICE 2008 guidelines2, upon which the MOSAICS trial
was based, the evidence about the role of paracetamol in thepharmacological management of OA has been questioned. Para-
cetamol was promoted as a ﬁrst-line pharmacological therapy
along with topical NSAIDs, and remains a recommended option in
the NICE 2014 guidelines. A recent systematic review32 concluded
that paracetamol adds little to the management of OA and does
have risks.
Jordan et al. previously described the practice-level evaluation
of the intervention in the cluster trial using the anonymised med-
ical records10. In practice records, supply of written information
increased in the intervention practices but remained stable in the
control practices10. We found similar results here in the patient-
reported QIs. Comparisons can also be made with other studies of
self-management in primary care. Kennedy et al.14, implementing
the WISE model of self-management support in primary care,
found a lack of clinical beneﬁt. However, our interventionwas more
intense, and we were able to detect change in quality indicators of
care e not measured by Kennedy et al.14 e by using patient self-
report. These included an increase in non-pharmacological ap-
proaches and a decline in use of oral NSAIDs. Unlike the study of
self-management by Buszewicz et al.33, which improved partici-
pants' perceived self-efﬁcacy to manage symptoms, we did not ﬁnd
a beneﬁt for pain self-efﬁcacy. However, we did notice an
improvement in patient enablement scores which could be regar-
ded consistent with Buszewicz's observation. A German cluster trial
of self-management support by GPs in adults aged 18 years with
hip and knee OA noted improvements in quality of life associated
with the addition of a practice nurse telephone follow-up to sup-
port self-management34. Further models of implementing OA
guidelines have been described, compared and contrasted35.
In conclusion, although our novel method of delivering and
supporting self-management for OA in general practice increased
the uptake of quality standards of OA care, there was no evidence of
beneﬁt of this intervention on the primary outcome of physical
functioning at 6 months.
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Appendix 1. Cluster trial eligibilityAppendix 2. The model OA consultation (MOAC) intervention
and training
The MOAC provided a new service for patients in general prac-
tice to enhance the management of OA based on the NICE OA
guidelines2,3. The model consultation was a linked GP and practice
nurse integrated consultation supported by the use of an OA
Guidebook13. The aim of the MOAC was to operationalise in general
practice three aspects of care for OA:
1. The three core treatments of the NICE OA Guideline (2008)2:
verbal and written information, advice to exercise and increase
physical activity, interventions to achieve weight loss.
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gesia: paracetamol and topical NSAIDs.
3. Support for self-management of OA based upon the Whole Sys-
tems Informing Self-Management Engagement (WISE) model14,
which centres on the provision of knowledge for patients and a
style of intervention built on professional responsiveness to pa-
tients' needs.Model OA consultation with the GP
Patients aged 45 years and over with peripheral joint pain (knee,
hip, hand, and foot) had an initial consultationwith the GP. An OA e-
template was triggered as part of the consultation and GPs were
asked to assess andmake a clinical diagnosis of the problemwithout
the routine use of X-ray. GPs were then asked to offer an explanation
of OA (in suitable language and tailored to the patient's level of un-
derstanding and individual circumstances) and offer ﬁrst line anal-
gesia as appropriate (paracetamol; topicalNSAIDS). AnOAguidebook
(http://www.keele.ac.uk/media/keeleuniversity/ri/primarycare/
pdfs/OA_Guidebook.pdf) written by patients and health care pro-
fessionals for patients was given to the patient. It offers support for
self-management, promotes the NICE core treatments and provides
accounts of how people live with OA. The GP was then asked to
explain the next steps: for the patient to read the OA guidebook and
to arrange a follow-up appointment with the practice nurse.
Model OA consultation with the practice nurse (nurse-led OA clinic)
The timing of the ﬁrst appointment with the practice nurse was
planned for a minimum of 2 weeks after the initial GP consultation.
This gave patients time to read the guidebook and try those self-
management strategies they felt were suitable. In the ﬁrst consul-
tation the practice nurse was asked to refer to the guidebook as a
resource to answer questions and clarify issues, ascertain the advice
from the GP consultation, negotiate and agree appropriate goals,
discuss the need for pain relief and opportunities for healthy eating,
physical activity and exercise as appropriate.
The timing of up to three follow-up visits with the nurse was
agreed between the patient and the practice nurse, but was
scheduled to be delivered within 3 months following the GP
consultation. The follow-up practice nurse consultations were
tailored to the patient's individual needs and could focus on, for
example, reviewing the self-management plan, demonstrating ex-
ercises (Arthritis Research UK Exercises for Arthritis leaﬂet), giving
advice as to how this could be maintained longer-term or making
any necessary referrals to the broader multidisciplinary team. The
practice nurse consultations were supported by a speciﬁcally
tailored Case Report Form (available on request) and a nurse toolkit
that included advice leaﬂets to give to patients (content of the
toolkit available on request).
Training
Training and educational packages were developed for GPs and
practice nurses by drawing on the work of May et al.28, Grol29 and
Michie et al.30 Intervention practices received practice updates on
core NICE recommendations for OA (diagnosis; written information
[an OA guidebook], exercise and physical activity, healthy eating,
pain management). GPs received training on the delivery of the
initial consultation for a new or established patient during four
practice-based sessions (2 h3,1 h1) utilising simulated patients
in skills training sessions15. Practice nurses received 4 days of
training on how to support patients to self-manage OA, using a
patient-centred approach, the OA guidebook, goal setting, painmanagement (analgesia and exercise) and the core NICE recom-
mendations (information and advice, strengthening exercise and
aerobic ﬁtness training, and weight management), again with the
use of simulated patients.
Members of the wider multidisciplinary team linked to the
intervention practices (e.g., physiotherapists, occupational thera-
pists, podiatrists, pharmacists) were invited to a workshop to
inform them of the use of the MOAC intervention in their local
general practice and its aims. They were given the OA guidebook as
referencematerial, however no change to usual carewas instigated.
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